TipRanks
Kyntra Bio (CH:KYNB)
:KYNB
Switzerland Market
KYNB
Kyntra Bio
RESEARCH TOOLSreports

Kyntra Bio (KYNB) Stock News & Sentiment

0 Followers
Kyntra Bio Faces Nasdaq Delisting, Appeals Listing Decision
Premium
Company Announcements
Kyntra Bio Faces Nasdaq Delisting, Appeals Listing Decision
1d ago
8K
KYNB
Kyntra Bio appoints new independent director, updates governance
Premium
Company Announcements
Kyntra Bio appoints new independent director, updates governance
7d ago
8K
KYNB
Kyntra Bio Streamlines Financing, Strengthens Balance Sheet
Premium
Company Announcements
Kyntra Bio Streamlines Financing, Strengthens Balance Sheet
1M ago
8K
KYNB
Kyntra Bio Earnings Call Highlights CD46 Oncology Push
Premium
Company Announcements
Kyntra Bio Earnings Call Highlights CD46 Oncology Push
1M ago
KYNB
Kyntra Earns Buy Rating on Strong Cash Runway and Multiple Late-Stage Clinical Catalysts
Premium
Ratings
Kyntra Earns Buy Rating on Strong Cash Runway and Multiple Late-Stage Clinical Catalysts
2M ago
KYNB
Kyntra Bio Confronts Nasdaq Listing Risk as Asset and Revenue Shortfall Threatens Global Select Status
Premium
Company Announcements
Kyntra Bio Confronts Nasdaq Listing Risk as Asset and Revenue Shortfall Threatens Global Select Status
2M ago
KYNB
KYNB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
KYNB Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
KYNB
More CH:KYNB News >

KYNB News on the Web

FibroGen Inc trading resumes
TipRanks News
Bullish
Wall Street Analysts Are Neutral on Top Healthcare Picks
TipRanks News
Neutral
Kyntra Bio cuts max royalty cap to $65M from $125M, pays $42.6M upfront
TipRanks News
Bullish
Kyntra Bio (KYNB) Q2 2026 Earnings Call Transcript
The Motley Fool
Neutral
Kyntra Bio Confronts Nasdaq Listing Risk as Asset and Revenue Shortfall Threatens Global Select Status
TipRanks News
Bearish
Oppenheimer Keeps Their Buy Rating on Kyntra Bio (KYNB)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Kyntra Bio (KYNB) and Minerva Neurosciences (NERV)
TipRanks News
Bullish
Q2 2026 Kyntra Bio, Inc. Earnings Call Transcript
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
CH:KYNB
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.5 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

FAQ

What is CH:KYNB’s Media Buzz Sentiment?
2 articles about CH:KYNB were published this week. In an average week, 1.5 articles are published.
    What is CH:KYNB’s weekly average amount of articles?
    In an average week, 1.5 articles about CH:KYNB are published.
      What is CH:KYNB’s News Sentiment?
      50% of articles about CH:KYNB were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XENEXenon
        ABTAbbott Laboratories
        BBIOBridgeBio Pharma
        BDXBecton Dickinson
        NVSNovartis
        Showing the stocks with the most bullish news sentiment over the past week